Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: Down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability
Authors:
- Xiangjian ZhangXZXiangjian Zhang
- 1 April 2010
- journal article
- Published by Elsevier in Brain Research
- Vol. 1325, 164-173
Abstract
No abstract availableKeywords
Funding Information
- Hebei Province (C2006000915, 06276103D)
This publication has 48 references indexed in Scilit:
- Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic StrokeStroke, 2009
- Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytesNeurochemistry International, 2008
- Protecting Against Cerebrovascular InjuryStroke, 2008
- Role of the p38 Mitogen-Activated Protein Kinase/Cytosolic Phospholipase A2 Signaling Pathway in Blood—Brain Barrier Disruption after Focal Cerebral Ischemia and ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2008
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative StressStroke, 2005
- Mevastatin, an HMG-CoA Reductase Inhibitor, Reduces Stroke Damage and Upregulates Endothelial Nitric Oxide Synthase in MiceStroke, 2001
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effectLife Sciences, 2000
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- A Novel Endothelin Antagonist, A-127722, Attenuates Ischemic Lesion Size in Rats With Temporary Middle Cerebral Artery OcclusionStroke, 1998